Quest Diagnostics Inc vs First Trust Cloud Computing ETF — how do they compare? Quest Diagnostics Inc trades at $204.5 (market cap $22.80B), while First Trust Cloud Computing ETF trades at $136.39. The key difference: Quest Diagnostics Inc pays a 1.67% dividend while First Trust Cloud Computing ETF pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, First Trust Cloud Computing ETF nearer its low. Which is the better fit depends on your goals.
| DGX | SKYY | |
|---|---|---|
Market Cap | $22.80B | — |
Sector | Health | — |
52-Week High | $216.02 | $155.17 |
52-Week Low | $166.42 | $104.16 |
Enterprise Value | $28.82B | — |
Dividend Yield | 1.67% | — |
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
SKYY (First Trust Cloud Computing ETF) trades at $139.99 with a slight 0.16% daily gain, showing bullish technical momentum with strong moving average support. The ETF benefits from ongoing technology sector inflows and enterprise cloud adoption trends. Recent news highlights continued institutional interest in cloud computing ETFs as hyperscalers pivot to AI-first platforms.
The outlook remains positive given strong technical indicators and sector tailwinds, though investors should monitor potential overbought conditions. Key risks include technology sector volatility and competitive ETF offerings. Analyst coverage suggests sustained interest in cloud computing exposure amid digital transformation acceleration.
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →